The potential role of precision medicine to alleviate racial disparities in prostate, bladder and renal urological cancer care
Abstract Background Racial disparities in oncological outcomes resulting from differences in social determinants of health (SDOH) and tumour biology are well described in prostate cancer (PCa) but similar inequities exist in bladder (BCa) and renal cancers (RCCs). Precision medicine (PM) aims to pro...
Main Authors: | Kunal K. Sindhu, Zachary Dovey, Marcher Thompson, Anthony D. Nehlsen, Karin A. Skalina, Beata Malachowska, Shaakir Hasan, Chandan Guha, Justin Tang, Lucas Resende Salgado |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2024-04-01
|
Series: | BJUI Compass |
Subjects: | |
Online Access: | https://doi.org/10.1002/bco2.323 |
Similar Items
-
Combining theranostic/particle therapy with immunotherapy for the treatment of GU malignancies
by: Karin A. Skalina, et al.
Published: (2024-03-01) -
Racial disparity in prostate cancer in the African American population with actionable ideas and novel immunotherapies
by: Zachary S. Dovey, et al.
Published: (2021-10-01) -
Racial Discrimination, Social Disadvantage, and Racial–Ethnic Disparities in COVID-19 Vaccine Uptake
by: Alein Y. Haro-Ramos, MPH, et al.
Published: (2023-06-01) -
Locking the Revolving Door: Racial Disparities in Cardiovascular Disease
by: Gladys Velarde, et al.
Published: (2023-04-01) -
Economic Competition and Racial/Ethnic Disparities in Sentencing: A Test of Economic Threat Perspective
by: Christopher D’Amato, et al.
Published: (2021-06-01)